Clinical trial

The Study of Atherosclerosis With Ramipril and Rosiglitazone

NCT00140647

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-07-01

PhasePHASE3

Study timeline

Study start (unknown)2001-07-01Date precision: month

Registry last updated2008-08-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Atherosclerosisunresolved

Impaired Glucose Toleranceunresolved

Isolated Impaired Fasting Glucoseunresolved

Cardiovascular Diseaseunresolved

Interventions

RamiprilDRUG · verified · RxNorm: ramipril

RosiglitazoneDRUG · verified · RxNorm: rosiglitazone

Sponsors & collaborators

Gerstein, Hertzel, MDlead sponsor

Heart and Stroke Foundation of Ontariocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00140647 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.